Immunologists break down the options for treating seasonal allergies depending on symptoms and severity. They share the most ...

Pollen season is getting longer and more intense, but these steps can keep you comfortableThe first line of defense against ...

Girls had a higher incidence of allergic rhinitis (AR) than boys, and boys had higher remission rates than girls, data from Sweden showed. Early sensitization increased the risk for AR and reduced ...

Glenmark Pharma on announced that its US subsidiary, Glenmark Therapeutics Inc, USA has been granted approval by the US Food & Drug Administration (USFDA) for its Olopatadine Hydrochloride ...

Glenmark Pharmaceuticals (-1.46%) received final approval from the USFDA for its Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC). This product is considered bioequivalent to Alcon ...

Glenmark Pharmaceuticals share price: The pharma major received final approval from the United States Food & Drug Administration (US FDA) for Olopatadine Hydrochloride Ophthalmic Solution, which will ...

You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma). 1 Glenmark’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) is only marketed for the ...

Share India Securities Ltd. is a Public Limited Listed company incorporated on 12/07/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) ...